CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-18 | Sturmer Michael E PRESIDENT | Grant or award · Option (Right to Buy) | +300,000 | 300,000 | ||
| 2022-10-18 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Grant or award · Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-10-18 | Schlanger David J Executive Chairman | Exercise or conversion | +32,459 | $0.91 | $30K | 115,007 |
| 2022-10-18 | Schlanger David J Executive Chairman | Sale | −31,596 | $39.62 | $1.3M | 83,411 |
| 2022-10-18 | Schlanger David J Executive Chairman | Sale | −863 | $40.43 | $35K | 82,548 |
| 2022-10-18 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −32,459 | 1,386,869 | ||
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +18,000 | $3.95 | $71K | 268,445 |
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −17,440 | $39.61 | $691K | 251,005 |
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −560 | $40.43 | $23K | 250,445 |
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,360 | $39.61 | $173K | 186,277 |
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −140 | $40.43 | $6K | 186,137 |
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −18,000 | 1,473,713 | ||
| 2022-10-18 | Anevski Peter CHIEF EXECUTIVE OFFICER | Grant or award · Option (Right to Buy) | +800,000 | 800,000 | ||
| 2022-10-17 | Schlanger David J Executive Chairman | Exercise or conversion | +1,300 | $0.91 | $1K | 83,848 |
| 2022-10-17 | Schlanger David J Executive Chairman | Sale | −1,300 | $39.34 | $51K | 82,548 |
| 2022-10-17 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −1,300 | 1,419,328 | ||
| 2022-10-17 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +400 | $3.95 | $2K | 250,845 |
| 2022-10-17 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −400 | $39.33 | $16K | 250,445 |
| 2022-10-17 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −100 | $39.33 | $4K | 190,637 |
| 2022-10-17 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −400 | 1,491,713 |
Page 40 of 77 · 1,524 trades